Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161941
Status:
COMPLETED
Last Update Posted:
2015-05-21
First Post:
2005-09-08
Brief Title:
Follow-up Study on the Antibody Response to Hepatitis B Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac Vaccination in Healthy Children Who Participated in NeisVac-C Study 216
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Open-label Multicenter Phase 3B Follow-up Study to Investigate the Antibody Response to Hepatitis B Acellular Pertussis Toxin and Inactivated Poliovirus Antigens One Month After the 4th Hexavac Vaccination in Healthy Children Who Participated in the NeisVac-C Non-interference Study 216
Status:
COMPLETED
Status Verified Date:
2015-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary aim of the study is to show that the antibody response to hepatitis B acellular pertussis toxin and inactivated poliovirus antigens after the 4th vaccination with Hexavac is not influenced by the concomitant administration of NeisVac-C
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None